CH
抗体药类似物
Research Grade Litifilimab
All
  • CatalogTD-HV560016
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsBIIB059,BIIB-059,BIIB059,CAS:2407378-48-5
  • Specification
    1mg
  • Prices
    ¥询价
Customized service consulting

Research Grade Litifilimab


Catalog No. TD-HV560016
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG1-kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target CLEC4C, C-type lectin superfamily member 7, CLECSF11, C-type lectin domain family 4 member C, Dendritic lectin, CD303, DLEC, HECL, Blood dendritic cell antigen 2, BDCA-2, BDCA2, CLECSF7
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession Q8WTT0
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names BIIB059,BIIB-059,BIIB059,CAS:2407378-48-5
Background Litifilimab is a humanized IgG1-κ antibody targeting to C-type lectin domain family 4 member C (CLEC4C). Litifilimab can be used for cutaneous lupus erythematosus (CLE) study.
Note For research use only. Not for use in clinical or therapeutic applications.